Lifecore Biomedical Inc (LFCR)
6.28
-0.29
(-4.41%)
USD |
NASDAQ |
May 10, 16:00
6.296
+0.02
(+0.25%)
Pre-Market: 20:00
Lifecore Biomedical Net Income (TTM): -100.12M for May 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| May 31, 2023 | -99.56M |
| February 28, 2023 | -119.59M |
| November 30, 2022 | -92.48M |
| August 31, 2022 | -118.48M |
| May 31, 2022 | -116.60M |
| February 28, 2022 | -63.50M |
| November 30, 2021 | -55.91M |
| August 31, 2021 | -30.77M |
| May 31, 2021 | -32.29M |
| February 28, 2021 | -44.95M |
| November 30, 2020 | -50.97M |
| August 31, 2020 | -44.41M |
| May 31, 2020 | -38.19M |
| February 29, 2020 | -23.30M |
| November 30, 2019 | -10.72M |
| August 31, 2019 | -4.562M |
| May 31, 2019 | 0.412M |
| February 28, 2019 | 6.781M |
| November 30, 2018 | 21.80M |
| August 31, 2018 | 22.87M |
| May 31, 2018 | 24.83M |
| February 28, 2018 | 21.17M |
| November 30, 2017 | 8.585M |
| August 31, 2017 | 9.424M |
| May 31, 2017 | 10.59M |
| Date | Value |
|---|---|
| February 28, 2017 | 12.87M |
| November 30, 2016 | -11.82M |
| August 31, 2016 | -11.28M |
| May 31, 2016 | -11.64M |
| February 29, 2016 | -12.17M |
| November 30, 2015 | 12.79M |
| August 31, 2015 | 14.14M |
| May 31, 2015 | 13.54M |
| February 28, 2015 | 13.89M |
| November 30, 2014 | 16.52M |
| August 31, 2014 | 16.75M |
| May 31, 2014 | 19.14M |
| February 28, 2014 | 19.12M |
| November 30, 2013 | 17.51M |
| August 31, 2013 | 22.97M |
| May 31, 2013 | 22.59M |
| February 28, 2013 | 20.85M |
| November 30, 2012 | 20.82M |
| August 31, 2012 | 15.25M |
| May 31, 2012 | 12.70M |
| February 29, 2012 | 7.18M |
| November 30, 2011 | 4.713M |
| August 31, 2011 | 3.428M |
| May 31, 2011 | 3.92M |
| February 28, 2011 | 5.189M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-119.59M
Minimum
Feb 2023
0.412M
Maximum
May 2019
-55.64M
Average
-44.95M
Median
Feb 2021
Net Income (TTM) Benchmarks
| Aquestive Therapeutics Inc | -28.77M |
| SELLAS Life Sciences Group Inc | -37.34M |
| ADMA Biologics Inc | -28.24M |
| Relmada Therapeutics Inc | -98.79M |
| Jaguar Health Inc | -41.30M |